vs
Side-by-side financial comparison of AGENUS INC (AGEN) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $34.2M, roughly 1.8× AGENUS INC). Ouster, Inc. runs the higher net margin — 6.4% vs -31.0%, a 37.4% gap on every dollar of revenue. On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 27.5%). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (51.8% CAGR vs 10.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
AGEN vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $62.2M |
| Net Profit | $-10.6M | $4.0M |
| Gross Margin | — | 60.2% |
| Operating Margin | 42.1% | 41.2% |
| Net Margin | -31.0% | 6.4% |
| Revenue YoY | 27.5% | 106.6% |
| Net Profit YoY | 77.3% | — |
| EPS (diluted) | $0.09 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $62.2M | ||
| Q4 25 | $34.2M | $62.2M | ||
| Q3 25 | $30.2M | $39.5M | ||
| Q2 25 | $25.7M | $35.0M | ||
| Q1 25 | $24.1M | $32.6M | ||
| Q4 24 | $26.8M | $30.1M | ||
| Q3 24 | $25.1M | $28.1M | ||
| Q2 24 | $23.5M | $27.0M |
| Q1 26 | — | $4.0M | ||
| Q4 25 | $-10.6M | — | ||
| Q3 25 | $63.9M | $-21.7M | ||
| Q2 25 | $-30.0M | $-20.6M | ||
| Q1 25 | $-26.4M | $-22.0M | ||
| Q4 24 | $-46.8M | — | ||
| Q3 24 | $-67.2M | $-25.6M | ||
| Q2 24 | $-54.8M | $-23.9M |
| Q1 26 | — | 60.2% | ||
| Q4 25 | — | 60.2% | ||
| Q3 25 | 97.9% | 42.1% | ||
| Q2 25 | 99.1% | 45.2% | ||
| Q1 25 | 99.4% | 41.3% | ||
| Q4 24 | 99.6% | 43.8% | ||
| Q3 24 | 99.4% | 38.3% | ||
| Q2 24 | 99.5% | 33.7% |
| Q1 26 | — | 41.2% | ||
| Q4 25 | 42.1% | 1.5% | ||
| Q3 25 | -15.0% | -61.4% | ||
| Q2 25 | -65.0% | -76.5% | ||
| Q1 25 | -55.3% | -73.0% | ||
| Q4 24 | -96.5% | -85.1% | ||
| Q3 24 | -125.5% | -98.0% | ||
| Q2 24 | -128.4% | -93.6% |
| Q1 26 | — | 6.4% | ||
| Q4 25 | -31.0% | — | ||
| Q3 25 | 211.4% | -55.0% | ||
| Q2 25 | -116.8% | -58.8% | ||
| Q1 25 | -109.6% | -67.5% | ||
| Q4 24 | -174.4% | — | ||
| Q3 24 | -267.7% | -91.1% | ||
| Q2 24 | -233.1% | -88.4% |
| Q1 26 | — | $0.06 | ||
| Q4 25 | $0.09 | $0.10 | ||
| Q3 25 | $1.94 | $-0.37 | ||
| Q2 25 | $-1.00 | $-0.38 | ||
| Q1 25 | $-1.03 | $-0.42 | ||
| Q4 24 | $-1.95 | $-0.46 | ||
| Q3 24 | $-3.08 | $-0.54 | ||
| Q2 24 | $-2.52 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $208.6M |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $261.7M |
| Total Assets | $226.8M | $349.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $208.6M | ||
| Q4 25 | $3.0M | $208.6M | ||
| Q3 25 | $3.5M | $244.5M | ||
| Q2 25 | $9.5M | $226.5M | ||
| Q1 25 | $18.5M | $168.2M | ||
| Q4 24 | $40.4M | $172.0M | ||
| Q3 24 | $44.8M | $151.4M | ||
| Q2 24 | $93.7M | $184.2M |
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $261.7M | ||
| Q4 25 | $-271.1M | $261.7M | ||
| Q3 25 | $-274.1M | $247.4M | ||
| Q2 25 | $-354.6M | $221.0M | ||
| Q1 25 | $-341.8M | $167.9M | ||
| Q4 24 | $-326.4M | $180.9M | ||
| Q3 24 | $-292.3M | $171.7M | ||
| Q2 24 | $-241.3M | $170.6M |
| Q1 26 | — | $349.5M | ||
| Q4 25 | $226.8M | $349.5M | ||
| Q3 25 | $233.9M | $353.8M | ||
| Q2 25 | $185.2M | $321.8M | ||
| Q1 25 | $200.2M | $268.6M | ||
| Q4 24 | $226.3M | $276.1M | ||
| Q3 24 | $238.5M | $255.2M | ||
| Q2 24 | $292.4M | $309.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-16.6M | $-15.4M | ||
| Q3 25 | $-14.7M | $-18.3M | ||
| Q2 25 | $-20.2M | $-1.3M | ||
| Q1 25 | $-25.6M | $-4.9M | ||
| Q4 24 | $-28.7M | $-2.6M | ||
| Q3 24 | $-53.3M | $-3.8M | ||
| Q2 24 | $-38.2M | $-21.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-37.2M | ||
| Q3 25 | — | $-20.0M | ||
| Q2 25 | $-20.2M | $-2.2M | ||
| Q1 25 | $-25.6M | $-5.4M | ||
| Q4 24 | $-28.7M | $-4.0M | ||
| Q3 24 | $-53.3M | $-4.3M | ||
| Q2 24 | $-38.6M | $-22.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | -59.8% | ||
| Q3 25 | — | -50.7% | ||
| Q2 25 | -78.7% | -6.3% | ||
| Q1 25 | -106.5% | -16.6% | ||
| Q4 24 | -107.0% | -13.3% | ||
| Q3 24 | -212.2% | -15.4% | ||
| Q2 24 | -164.4% | -81.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 35.0% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 1.7% | ||
| Q4 24 | 0.3% | 4.8% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 2.0% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
OUST
| Product revenue | $41.0M | 66% |
| Royalties | $21.2M | 34% |
